BTMD biote Corp.

BTMD financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1819253 Exchange: Nasdaq SIC: 2833 (Medicinal Chemicals & Botanical Products) Latest filing: 10-Q filed Aug 7, 2026 Data checked: Oct 21, 2026
Showing 3 of 5 annual and 0 of 22 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity Type
Operating
Public Float
$97.90M (Jun 2025)
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Fiscal Year End
December (1231)
Phone
972-486-9346
EIN
851791125
Headquarters
IRVING, TX, 75038
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: Haymaker Acquisition Corp. III (2020–2022)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$183.53M
Net Income
$5.86M
Total Assets
$101.70M
Total Equity
$-58.19M
Total Debt
$121.50M
Free Cash Flow
$19.87M
Ratios
Gross Margin
68.6%
Operating Margin
8%
Net Margin
3.2%
Return on Equity
-10.1%
Return on Assets
5.8%
Current Ratio
1.43x
Debt / Equity
-2.09x
FCF / Assets
19.5%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

biote Corp. generated $192.22M of revenue in fiscal 2025, with net income of $27.05M and an operating cash inflow of $35.19M. At $192.22M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. The top line contracted 2.5% from $197.19M in fiscal 2024; this top-line contraction left the company with a smaller revenue base. Diluted earnings per share were $0.74, translating the period’s attributable earnings into the amount reported for each diluted share. Against diluted EPS of $0.09 in fiscal 2024, the current result was 722.2% higher.

Profitability

The first profit layer was $137.36M of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross margin was 71.5%, so that share of each revenue unit remained after the cost of revenue reported for the period. Operations produced $35.55M of income after the reported operating expense base, before the remaining non-operating and tax effects. Relative to revenue, operating income represented 18.5%, showing how efficiently sales converted into operating profit. The bottom-line result was net income of $27.05M, after the operating, financing, tax, and other items recognized for the period. The final earnings result represented 14.1% of revenue, connecting the absolute net income figure with the company’s top-line scale. Pretax income was $37.58M, isolating the reported earnings outcome before the income-tax provision recognized for the fiscal year. Pretax income represented 19.6% of revenue, placing earnings before tax in the context of the company’s operating scale. Income tax expense totaled $5.99M, providing the reported tax component that separates pretax and after-tax earnings. The income-tax provision equaled 15.9% of pretax income, showing the tax burden absorbed by the year’s earnings.

Liquidity and Capital Structure

Total assets were $107.61M, supported by $158.01M of liabilities and -$50.40M of shareholder equity. With total equity at -$50.40M, the company carried a negative book-capital position, increasing its reliance on liabilities and future earnings. At period end, current assets of $54.67M compared with current liabilities of $44.99M, defining the company’s short-term resource position. The current ratio was 1.22x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Cash and equivalents totaled $24.12M, identifying the most liquid reported component available within the broader current-asset balance. The cash balance equaled 53.6% of current liabilities, showing how much near-term coverage came from cash alone. Total debt was $102.03M, establishing the amount of borrowing carried within the company’s capital structure. Relative to total assets, debt measured 94.8%, showing how much of the asset base was matched by borrowing. Relative to total assets, liabilities measured 146.8%, complementing the separate equity-based view of the company’s capital structure. Cash and equivalents equaled 22.4% of total assets, showing the liquid cash component within the company’s broader resource base.

Cash Flow and Earnings Quality

Cash flow from operations was $35.19M, a reported cash inflow that can be compared directly with net income and capital spending. Against net income, operating cash flow measured 1.3x, showing the relationship between accrual earnings and operating cash. The cash-flow statement records $5.01M of capital expenditures, the investment amount considered after operating cash generation. Capital spending absorbed 14.2% of operating cash flow, quantifying the share of cash from operations directed to investment. After capital spending, free cash flow was $30.18M, leaving cash available for debt reduction, shareholder returns, or further investment. Free cash flow represented 15.7% of revenue, linking post-investment cash generation with the company’s operating scale. The free-cash-flow-to-assets relationship was 28.0%, comparing post-investment cash with the balance-sheet asset base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for biote Corp.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $192.22M $197.19M $185.36M
Cost of Revenue $54.86M $58.13M $57.88M
Gross Profit $137.36M $139.06M $127.48M
OPERATING EXPENSES
SG&A Expense $101.81M $107.45M $98.83M
Operating Income $35.55M $31.61M $28.66M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $-29.00K $11.00K $-16.00K
Pretax Income $37.58M $1.02M $-123.00K
Income Tax $5.99M $970.00K $2.68M
Net Income $27.05M $3.16M $3.32M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.74 $0.09 $0.13
Diluted Shares 36.67M 34.27M 25.71M
EBITDA $39.22M $35.19M $31.65M
Depreciation & Amortization $3.67M $3.57M $2.99M
Balance Sheet
ASSETS
Cash & Equivalents $24.12M $39.34M $89.00M
Accounts Receivable $6.87M $7.63M $6.81M
Inventory $19.06M $14.85M $17.31M
Other Current Assets $10.00K $111.00K $308.00K
Current Assets $54.67M $68.13M $122.34M
PP&E (Net) $10.75M $6.97M $1.22M
Goodwill $5.83M $5.83M -
Intangible Assets $4.27M $5.50M $0
Other Noncurrent Assets $72.00K $72.00K -
Noncurrent Assets $52.94M $54.24M $32.95M
Total Assets $107.61M $122.37M $155.30M
LIABILITIES
Accounts Payable $6.83M $5.81M $4.16M
Short-term Debt $6.25M $6.25M $6.25M
Other Current Liabilities $1.79M $1.51M $1.85M
Current Liabilities $44.99M $51.51M $22.22M
Long-term Debt $95.78M $101.20M $106.63M
Other Noncurrent Liabilities (derived) $344.00K $1.50M $63.00M
Noncurrent Liabilities $113.02M $173.06M $169.63M
Total Liabilities $158.01M $224.57M $191.84M
EQUITY
Additional Paid-in Capital $0 $0 $0
Retained Earnings $-49.55M $-100.30M $-29.39M
Accumulated OCI $-29.00K $-35.00K $-12.00K
Total Equity $-50.40M $-102.20M $-36.55M
Total Liabilities & Equity $107.61M $122.37M $155.30M
SUPPLEMENTAL
Total Debt $102.03M $107.45M $112.88M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $35.19M $45.24M $26.88M
Capital Expenditures $5.02M $6.43M $359.00K
Cash from Investing $-6.86M $-18.80M $-2.71M
Cash from Financing $-43.56M $-76.08M $-14.38M
Free Cash Flow $30.18M $38.81M $26.52M
Beginning Cash (CFS) $39.34M $89.00M $79.23M
Net Change in Cash $-15.23M $-49.64M $9.79M
Effect of FX on Cash $6.00K $-22.00K $-19.00K
Calculated Ending Cash $24.12M $39.34M $89.00M
Cash per BS $24.12M $39.34M $89.00M
Cash scope difference (CFS − BS) - - -
Cash per CFS $24.12M $39.34M $89.00M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is biote Corp.'s annual revenue?

biote Corp. reported $183.53M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is biote Corp. profitable?

Yes. biote Corp. reported $5.86M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is biote Corp.'s debt level?

biote Corp. carries $121.50M in total debt as of trailing twelve months. Total shareholders' equity stands at $-58.19M.

Does biote Corp. generate free cash flow?

Yes. Free cash flow was $19.87M for trailing twelve months. Operating cash flow was $24.37M.